Calcitriol has been proven to mediate the chemopreventive function of growth inhibitors and effectively enhance the inhibitory effects of erlotinib (an anti-EGFR mAb) against tumour proliferation in a patient-derived xenograft model of HNSCC [200]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.